Forecast & Rating8 analysts currently cover Kestra Medical Tech, with about 87.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $30.29, about 20.0% upside from the current price of $25.25. Price targets are fairly clustered, pointing to relatively aligned views. For you, this means most professionals who study Kestra Medical Tech closely still see room for the stock to rise. Data as of Sep 15, 2026; for reference only and not investment advice.
Sep 15, 2026Price forecast
$30.2919.97%
Forecast & RatingBuy
8analysts
- Strong buy62.50%
- Buy25.00%
- Hold12.50%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 16, 2026
Forecast met48.5%
Stock price$25.25
Avg. target$29.1
High target$32
Low target$25
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.